Sarclisa
Sanofi’s Sarclisa gains new US multiple myeloma indication
Richard Staines
multiple myeloma, Sanofi, Sarclisa
0 Comment
News/ News/ Oncology/ Top stories
Kiadis Pharma and Sanofi to unlock power of natural killer cells in multiple myeloma
Richard Staines
Kiadis, multiple myeloma, Sanofi, Sarclisa
0 Comment
News/ News/ News/ Oncology/ R&D
Sanofi builds case for Sarclisa, challenging J&J’s Darzalex
Phil Taylor
Darzalex, Johnson & Johnson, multiple myeloma, Oncology, Sanofi, Sarclisa
0 Comment
News/ News/ Oncology/ Top stories
Sanofi gets first OK for isatuximab for myeloma, challenging J&J’s Darzalex
Phil Taylor
Darzalex, multiple myeloma, Oncology, Sanofi, Sarclisa
0 Comment